Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. inflammatory response
Show results for
Products
Services
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Inflammatory Response Articles & Analysis

47 news found

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...

BySCIREQ - an emka TECHNOLOGIES Company


The Impact of Landscape Fire Smoke On Respiratory and Cardiac Health

The Impact of Landscape Fire Smoke On Respiratory and Cardiac Health

The incidence of landscape fires has been rising globally, leading to increased exposure to landscape fire smoke (LFS) among millions of people. The inhalation of particulate matter (PM) from LFS is associated with adverse respiratory and cardiovascular outcomes. However, the mechanisms by which LFS impacts these functions remain inadequately understood. This blog focuses on a new ...

BySCIREQ - an emka TECHNOLOGIES Company


Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung damage such as fibrosis. A groundbreaking study has developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), which shows significant potential as a therapeutic agent. This ...

BySCIREQ - an emka TECHNOLOGIES Company


Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

CD Formulation's extensive range of APIs can be classified into amino acid series, antibacterial, anti-inflammatory and antiviral series, cardiovascular series, hormone series and other APIs. ...

ByCD Formulation


Q-switched Nd:YAG laser for pigmented lesions

Q-switched Nd:YAG laser for pigmented lesions

The Q switched Nd YAG laser tattoo removal machine is ideal for pigmented lesions such as nevus of Ota, all types of tattoos, eyebrow tattoos, eyeliner tattoos, pigmentation of foreign bodies on the skin and freckles and age spots. Bvlaser is a professional ND YAG laser machine manufacturer, we have Q switch ND:YAG laser melasma age pigment machine for sale. Principle of the Q-switched Nd:YAG ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and inflammatory signaling. Alfa Chemistry offers tofacitinib citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific requirements of different research projects. ...

ByAlfa Chemistry


The CO2 fractional laser skin resurfacing in action

The CO2 fractional laser skin resurfacing in action

The best CO2 fractional laser machine is a laser treatment for spots, wrinkles, scars and warts, which is usually a type of laser that stimulates the skin tissue through the focused energy emitted by the gas laser. Which not only blasts the melanin particles on the surface instantly, but also stimulates the collagen tissue underneath the skin to gradually repair the skin. It also stimulates the ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


BIOtechNOW featured IVS’s participating BIO Innovation Zone

BIOtechNOW featured IVS’s participating BIO Innovation Zone

Our tissues are reproducible, uniform, have long-term consistent and accurate functionality and responsiveness to cardio-active and cardio-toxic substances and will be an ideal in vitro model for the study of acute and chronic ...

ByInvivoSciences, Inc. (IVS)


BRIM Biotech submits US Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease to the FDA

BRIM Biotech submits US Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease to the FDA

Restasis and Xiidra work by inhibiting the inflammatory response of DED and stimulating tear production, but these drugs are expensive and accompanied by some unwanted side effects, such as burning and dysgeusia. ...

ByBRIM Biotechnology, Inc.


Gesynta Pharma prepares Phase II study of GS-248 in endometriosis following ground-breaking data from a preclinical proof-of-concept study

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis following ground-breaking data from a preclinical proof-of-concept study

Gesynta Pharma AB today announces the decision to advance the development of its clinical-stage drug candidate GS-248 in endometriosis - a chronic inflammatory condition affecting approximately 10 percent of all women of reproductive age. This strategically important decision follows a recent preclinical proof-of-concept study with GS-248 in an advanced model of endometriosis, where ...

ByGesynta Pharma AB


CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

However, results recently published from a single-center feasibility study at Macquarie University Hospital in Australia showed that the AeriSeal System successfully closed collateral air channels and allowed for successful clinical outcomes after treatment with Zephyr Valves.2 At 6 months, AeriSeal and Zephyr Valve treated CV+ patients experienced clinically meaningful improvements similar to ...

ByPulmonx Corporation


Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Cytokine recently launched the Mouse Cytokine Assay with high sensitivity to support research in immune responses, inflammatory diseases, allergies, sepsis, and cancer. Cytokines play an important role in physiological and pathological processes such as immune cell differentiation and subset development, immune regulation, ...

ByCreative Proteomics


TikoMed AB reports positive phase II clinical data for the treatment of Amyothropic Lateral Sclerosis in data published by PLOS ONE

TikoMed AB reports positive phase II clinical data for the treatment of Amyothropic Lateral Sclerosis in data published by PLOS ONE

“Preclinical studies from our ILB program have also demonstrated the drug’s unique ability to enhance endogenous repair mechanisms and rebalance inflammatory responses providing a new, potentially invaluable mechanism of action in the treatment of neurodegenerative diseases” ...

ByTIKOMED AB


Fecal biomarkers - diagnostic possibilities in the context of inflammatory bowel disease

Fecal biomarkers - diagnostic possibilities in the context of inflammatory bowel disease

Inflammatory bowel disease (IBD), mainly divided into Crohn's disease (CD) and ulcerative colitis (UC), are diseases whose causes are not fully understood and for which there is no cure. The chronic progression of IBD is characterized by periods of symptomatic relapses and symptom-free phases. During relapses, acute inflammation occurs in the bowel of IBD patients, leading to typical symptoms ...

ByImmundiagnostik AG


Major Biomedical Catalyst grant win

Major Biomedical Catalyst grant win

£1 million grant will support first-in-human clinical trials of H-Guard Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has been awarded a £1 million grant to bring H-Guard, its proprietary priming solution, designed to reduce the life-threatening ...

ByInvizius Limited


TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool Device for the Treatment of Concussions

TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool Device for the Treatment of Concussions

By interrupting the body’s naturally occurring localized inflammatory response with the introduction of cold therapy, the cellular metabolic cascade is dampened, thereby minimizing the ensuing damage caused by the body in response to injury. ...

ByTecTraum Inc.


Second grant win to research Peritoneal Dialysis indication

Second grant win to research Peritoneal Dialysis indication

Invizius Limited (“Invizius”), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today announces that it has been awarded a second Biomedical Catalyst grant (Feasibility & Primer Award) by Innovate UK to research a new field of application for its H-Guard technology. ...

ByInvizius Limited


Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

The presence of neutrophils in the lung is correlated to an inflammatory response and as such is clinically useful in the acute care setting to improve diagnosis of critically ill patients. ...

ByEdinburgh Molecular Imaging


LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

The funds will be used to develop a rapid, quantitative, multiplexed test for C-reactive proteins (CRP), inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers, which are known as cytokines and chemokines. The LightDeck® Analyzer’s inflammation panel is expected to help healthcare providers determine the status of a patient’s health and the ...

ByLightDeck Diagnostics


World Health Organization Panel Strongly Recommends The Use Of Baricitinib To Treat Hospitalised Patients With COVID-19

World Health Organization Panel Strongly Recommends The Use Of Baricitinib To Treat Hospitalised Patients With COVID-19

BenevolentAI scientists then supplemented this with relevant biological context so that the network represented, at a molecular level, how SARS-CoV-2 enters and infects cells, as well as the potentially lethal inflammatory response, the so-called ‘cytokine storm’. Focusing on these aspects, the scientific team short-listed 40 drugs, finally ...

ByBenevolent

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT